Competitive potentiation of acetylcholine effects on neuronal nicotinic receptors by acetylcholinesterase-inhibiting drugs

Journal of Neurochemistry

Volumn 75, Issue 6, 2000, Pages 2492-2500

  Zwart, R ^a   Van Kleef, R G D M ^a   Gotti, C ^a   Smulders, C J G M ^a   Vijverberg, H P M ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Acetylcholinesterase inhibitor; Neuronal nicotinic acetylcholine receptor; Physostigmine; Tacrine; Two site receptor occupation model; Xenopus oocyte

Indexed keywords

ACETYLCHOLINE; CHOLINESTERASE INHIBITOR; EPIBATIDINE; NICOTINIC RECEPTOR; PHYSOSTIGMINE; RECEPTOR SUBTYPE; TACRINE;

ANIMAL CELL; ARTICLE; BINDING COMPETITION; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DRUG RECEPTOR BINDING; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VOLTAGE CLAMP; XENOPUS LAEVIS;

ACETYLCHOLINE; ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; BINDING, COMPETITIVE; CELLS, CULTURED; CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ION TRANSPORT; LIGANDS; MODELS, NEUROLOGICAL; NICOTINIC AGONISTS; OOCYTES; PATCH-CLAMP TECHNIQUES; PHYSOSTIGMINE; PYRIDINES; RADIOLIGAND ASSAY; RATS; RECEPTORS, NICOTINIC; TACRINE; XENOPUS LAEVIS;

ANIMALIA; XENOPUS LAEVIS;

EID: 0033773350     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.0752492.x     Document Type: Article

References (36)

1. Epibatidine, a potent analgetic and nicotinic agonist
2. The cholinergic hypothesis of geriatric memory dysfunction
3. Open channel block by physostigmine and procaine in embryonic-like nicotinic receptors of mouse muscle
4. Unusual pharmacology of (+)-tubocurarine with rat neuronal nicotinic acetylcholine receptors containing β4 subunits
5. Blockade of nicotinic responses by physostigmine, tacrine and other cholinesterase inhibitors in rat striatum
6. Pharmacology of the nicotinic acetylcholine receptor from fetal rat muscle expressed in Xenopus oocytes
7. Primary structure and expression of β2: A novel subunit of neuronal nicotinic acetylcholine receptors
8. The functional diversity of the neuronal nicotinic acetylcholine receptors is increased by a novel subunit: β4
9. Symptomatic treatments for Alzheimer's disease
10. Cholinesterase inhibitors for Alzheimer's disease therapy: From tacrine to future applications
11. Members of a nicotinic acetylcholine receptor gene family are expressed in different regions of the mammalian central nervous system
12. 4-Oxystilbene compounds are selective ligands for neuronal nicotinic α-bungarotoxin receptors
13. Toward a structural basis for the function of nicotinic acetylcholine receptors and their cousins
14. Alzheimer's disease: The tacrine legacy
15. Ivermectin: A positive allosteric effector of the α7 neuronal nicotinic acetylcholine receptor
16. Neuronal nicotinic acetylcholine receptors as novel drug targets
17. Physostigmine and neuromuscular transmission
18. α4, but not α3 and α7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease
19. LIGAND: A versatile computerized approach for characterization in agonist binding affinity
20. Direct actions of anticholinesterases on the neuronal nicotinic acetylcholine receptor channels
21. A second pathway of activation of the Torpedo acetylcholine receptor channel
22. Neuronal nicotinic receptor β2 and β4 subunits confer large differences in agonist binding affinity
23. Identification and functional characterization of a new agonist site on nicotinic acetylcholine receptors of cultured hippocampal neurons
24. Physostigmine and galanthamine: Probes for a novel binding site on the α4β2 subtype of neuronal nicotinic acetylcholine receptors stably expressed in fibroblast cells
25. The cholinergic hypothesis - Ten years on
26. Interaction of 9-amino-1, 2, 3, 4-tetrahydroaminoacridine (THA) with human cortical nicotinic and muscarinic receptor binding in vitro
27. Agonist responses of neuronal nicotinic acetylcholine receptors are potentiated by a novel class of allosterically acting ligands
28. Antagonist and partial agonist actions of d-tubocurarine at mammalian muscle acetylcholine receptors
29. Physostigmine, galanthamine and codeine act as 'noncompetitive nicotinic receptor agonists' on clonal rat phaeochromocytoma cells
30. Physostigmine and acetylcholine differentially activate nicotinic receptor subpopulations in Locusta migratoria neurons
31. Physostigmine block of ion channels activated by acetylcholine in BC3H1 cells
32. Epibatidine and ABT 418 reveal selective losses of α4β2 nicotinic receptors in Alzheimer brains
33. Effect of in vivo microdialysis of 1, 2, 3, 4-tetrahydro-9-aminoacridine (THA) on the extracellular concentration of acetylcholine in the striatum of anesthetized rats
34. Potentiation and inhibition of neuronal nicotinic receptors by atropine: Competitive and noncompetitive effects
35. Differential modulation of α3β2 and α3β4 neuronal nicotinic receptors expressed in Xenopus oocytes by flufenamic acid and niflumic acid
36. Physostigmine and atropine potentiate and inhibit neuronal α4β4 nicotinic receptors